Comorbidities in Adolescents With Congenital Heart Disease: A Population-based Study
Matthew R. Reeder(Cleveland Clinic), Jennifer S. Li(Duke University), Amber Khanna(Children's Hospital Colorado), Kevin J. Whitehead(University of Utah), Marcia L. Feldkamp(University of Utah), George K. Lui(Stanford Medicine), Aida Soim(New York State Department of Health), Fred H. Rodriguez(Emory University Hospital), Lorenzo D. Botto(Centers for Disease Control and Prevention), Karrie F. Downing(Centers for Disease Control and Prevention), Alfred D’Ottavio(Duke University), Sergey Krikov(University of Utah), Jesse DeLaRosa(Clinical Research Institute), Tessa Crume(Colorado School of Public Health), Jill Glidewell(Centers for Disease Control and Prevention), Wendy M. Book(Emory University), Cheryl Raskind‐Hood(Emory University), Daphne T. Hsu, Nelangi M. Pinto(University of Washington), Karen Chiswell(Amyloidosis Foundation)
Cited by 1
Related Papers
Long-term Cardiovascular Toxicity in Children, Adolescents, and Young Adults Who Receive Cancer Therapy: Pathophysiology, Course, Monitoring, Management, Prevention, and Research Directions
|Circulation|2013|612
Racial and Temporal Variations in the Prevalence of Heart Defects
|PEDIATRICS|2001|575
Mortality Associated With Congenital Heart Defects in the United States
|Circulation|2001|567
Seeking causes: Classifying and evaluating congenital heart defects in etiologic studies
|Birth Defects Research Part A Clinical and Molecular Teratology|2007|464